Management to host conference call on Monday, January 8, 2024, at 8:00 am ET
Company also to present at the Biotech Showcase
FLORHAM PARK, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host a call detailing top-line data from its pivotal trial of iopofosine I 131 in Waldenstrom's macroglobulinemia on Monday, January 8, 2024 at 8:00 am ET. The company will also be presenting at the Biotech Showcase conference the following day. Details for each event are as follows:
Top-line Conference call details: | |
Date: | Monday, January 8, 2024 |
Time: | 8:00 am ET / 5:00 am PT |
Dial-in: | 1-888-886-7786 |
Webcast Link: | Click HERE |